In Case You Missed It: Highlights From the 2022 APA Annual Meeting

Catch up on the latest research on ADHD, PTSD, and more with Psychiatric Times.


Psychiatric TimesTM was onsite for the 2022 American Psychiatric Association (APA) Annual Meeting in New Orleans, Louisiana, covering expert opinions and the latest research on a wide variety of important psychiatric issues. Here are some highlights from our coverage.

Willpower and ADHD


“Why is it that people with ADHD can do some specific things that they happen to be really interested in, or where they feel like, if they don’t take care of this right here, right now, something they do not want to see happen is going to happen fast?”

Thomas E. Brown, PhD, of the Brown Clinic for ADHD and Related Disorders and the University of California-Riverside School of Medicine shared with 2022 American Psychiatric Association (APA) Annual Meeting attendees that attention-deficit/hyperactivity disorder (ADHD) may appear to be a problem of motivation, or “willpower,” but it is not. Continue Reading

More Than a Knockout: Structural Brain Effects in MMA Sparring

Sergey Ryzhov AdobeStock

In a first-of-its-kind study, researchers looked at the effect of practice sparring on possible brain changes in mixed martial arts (MMA) fighters. The results were presented at the 2022 American Psychiatric Association Annual Meeting by study author Aaron I. Esagoff, a medical student at Johns Hopkins University School of Medicine.

Although previous studies have looked at other sports that involve repetitive brain injury, the real risk for MMA fighters occur during practice sessions, explained Esagoff. Fights/matches only happen a few times per year, but individuals can spend hundreds of hours sparring and practicing. MMA is a hybrid combat sport that includes moves from boxing, wrestling, karate, judo, and jujitsu. Continue Reading

Understanding the Neurobiology of PTSD

Andrey Popov_AdobeStock

“I think until we really understand the underlying neurobiology of PTSD, we’re stuck with a situation where the patient gets better, but they don’t get well.”

Charles B. Nemeroff, MD, PhD, Matthew P. Nemeroff Endowed Chair and professor in the University of Texas at Austin (UT Austin) Dell Medical School Department of Psychiatry & Behavioral Sciences, discussed the neurobiology of posttraumatic stress disorder (PTSD) at the 2022 American Psychiatric Association Annual Meeting. In the session—moderated by Edmond Hsin T. Pi, MD—Nemeroff described the diagnosis, epidemiology, and pathophysiology of PTSD, along with notable risk factors and some current and emerging treatments for PTSD. Continue Reading

Leading the Artificial Intelligence Revolution


“Artificial intelligence (AI) is here to stay, and it’s really very important for the psychiatric field to take a leading role in developing it.”

P. Murali Doraiswamy, MBBS, FRCP, of the Duke University School of Medicine discussed some of the latest developments in AI and its current and potential applications for psychiatry at the 2022 American Psychiatric Association (APA) Annual Meeting. He was joined in a panel discussion by Robert M. Califf, MD, MACC, commissioner of food and drugs for the US Food and Drug Administration (FDA), and moderator Samantha Boardman, MD, psychiatrist and author of Everyday Vitality: Turning Stress Into Strength. Continue Reading

See more Psychiatric TimesTM coverage from the 2022 APA Annual Meeting here. And be sure to stay up-to-date by subscribing to the Psychiatric TimesTM E-newsletter.

Do you have a comment on any of these or other articles? Have a good idea for an article and want to write? Interested in sharing your perspectives? Write to us at

Related Videos
View All
© 2023 MJH Life Sciences

All rights reserved.